AP607A - Inhibiting photodecomposition of 3-substituted-2-oxindoles. - Google Patents

Inhibiting photodecomposition of 3-substituted-2-oxindoles. Download PDF

Info

Publication number
AP607A
AP607A APAP/P/1996/000787A AP9600787A AP607A AP 607 A AP607 A AP 607A AP 9600787 A AP9600787 A AP 9600787A AP 607 A AP607 A AP 607A
Authority
AP
ARIPO
Prior art keywords
red
yellow
dye
lake
thienyl
Prior art date
Application number
APAP/P/1996/000787A
Other languages
English (en)
Other versions
AP9600787A0 (en
Inventor
Jr Willard C Newlin
Sharon M Laughlin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AP9600787A0 publication Critical patent/AP9600787A0/xx
Application granted granted Critical
Publication of AP607A publication Critical patent/AP607A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polymerisation Methods In General (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
APAP/P/1996/000787A 1995-04-24 1996-03-07 Inhibiting photodecomposition of 3-substituted-2-oxindoles. AP607A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1995/000287 WO1996033701A1 (fr) 1995-04-24 1995-04-24 Inhibition de la photodecomposition des 2-oxindoles-3-substitues

Publications (2)

Publication Number Publication Date
AP9600787A0 AP9600787A0 (en) 1996-04-30
AP607A true AP607A (en) 1997-08-27

Family

ID=36997502

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1996/000787A AP607A (en) 1995-04-24 1996-03-07 Inhibiting photodecomposition of 3-substituted-2-oxindoles.

Country Status (30)

Country Link
EP (1) EP0827399A1 (fr)
JP (1) JPH10506635A (fr)
KR (1) KR100189585B1 (fr)
CN (1) CN1053667C (fr)
AP (1) AP607A (fr)
AR (1) AR002728A1 (fr)
AU (1) AU692378B2 (fr)
BG (1) BG100531A (fr)
BR (1) BR9602024A (fr)
CO (1) CO4700418A1 (fr)
FI (1) FI973988A0 (fr)
HR (1) HRP960194A2 (fr)
HU (1) HU216544B (fr)
IL (1) IL117969A0 (fr)
IS (1) IS4339A (fr)
MA (1) MA23848A1 (fr)
NO (1) NO961622L (fr)
NZ (1) NZ286432A (fr)
OA (1) OA10286A (fr)
PE (1) PE34397A1 (fr)
RO (1) RO113305B1 (fr)
RU (1) RU2109510C1 (fr)
SG (1) SG64924A1 (fr)
SI (1) SI9600133A (fr)
SK (1) SK51296A3 (fr)
TR (1) TR199600300A2 (fr)
UA (1) UA42739C2 (fr)
WO (1) WO1996033701A1 (fr)
YU (1) YU25096A (fr)
ZA (1) ZA963210B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3731654A1 (fr) 2017-12-29 2020-11-04 Kraft Foods Group Brands LLC Stabilité oxydative améliorée d'émulsions huile dans eau à l'aide de stabilisants naturels

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2246072A (en) * 1990-07-20 1992-01-22 Egyt Gyogyszervegyeszeti Gyar Pharmaceutical compositions stabilised against light
WO1994007488A1 (fr) * 1992-10-07 1994-04-14 Pfizer Inc. Compositions pharmaceutiques de 2-oxindole-1-carboxamide a substitution en position 3

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2246072A (en) * 1990-07-20 1992-01-22 Egyt Gyogyszervegyeszeti Gyar Pharmaceutical compositions stabilised against light
WO1994007488A1 (fr) * 1992-10-07 1994-04-14 Pfizer Inc. Compositions pharmaceutiques de 2-oxindole-1-carboxamide a substitution en position 3

Also Published As

Publication number Publication date
AP9600787A0 (en) 1996-04-30
HUP9601057A3 (en) 1997-05-28
TR199600300A2 (tr) 1996-11-21
NZ286432A (en) 1998-05-27
JPH10506635A (ja) 1998-06-30
MA23848A1 (fr) 1996-12-31
FI973988A (fi) 1997-10-17
OA10286A (en) 1997-09-19
PE34397A1 (es) 1997-09-29
NO961622D0 (no) 1996-04-23
KR960037656A (ko) 1996-11-19
WO1996033701A1 (fr) 1996-10-31
BG100531A (en) 1997-06-30
SG64924A1 (en) 1999-05-25
RU2109510C1 (ru) 1998-04-27
AU692378B2 (en) 1998-06-04
NO961622L (no) 1996-10-25
CN1053667C (zh) 2000-06-21
CN1139110A (zh) 1997-01-01
SI9600133A (en) 1996-10-31
HU9601057D0 (en) 1996-06-28
ZA963210B (en) 1997-10-23
SK51296A3 (en) 1997-04-09
EP0827399A1 (fr) 1998-03-11
RO113305B1 (ro) 1998-06-30
AU5085196A (en) 1996-11-07
IS4339A (is) 1996-10-25
HU216544B (hu) 1999-07-28
IL117969A0 (en) 1996-08-04
AR002728A1 (es) 1998-04-29
FI973988A0 (fi) 1997-10-17
KR100189585B1 (ko) 1999-06-01
CO4700418A1 (es) 1998-12-29
HRP960194A2 (en) 1998-02-28
YU25096A (sh) 1998-08-14
UA42739C2 (uk) 2001-11-15
BR9602024A (pt) 1998-10-06
HUP9601057A2 (en) 1997-04-28

Similar Documents

Publication Publication Date Title
CA1303504C (fr) Preparation pharmaceutique contenant de l'acrivastine
RU2140782C1 (ru) Улучшенные фармацевтические препараты, содержащие ибупрофен и кодеин
CA2501587C (fr) Preparation solide ayant une phase contenant un melange homogene d'un sensibilisateur a l'insuline et d'un autre ingredient actif
NZ270748A (en) Sustained release dosage form of alfuzosin hydrochloride coated with a ph-dissolution dependent polymer
ATE195073T1 (de) Feste pharmazeutische zubereitung mit (s)-2-(4- isobutylphenyl)propionsäure als wirkstoff und mikrokristalliner cellulose und kolloidalem silica als hilfstoff
CA1300509C (fr) Compositions pharmaceutiques pour la dysmenorrhee ou le syndrome premenstruel et son processus
KR20100012105A (ko) 인슐린 감작제, 인슐린 분비촉진제 및 폴리옥시에틸렌 소르비탄 지방산 에스테르를 함유하는 고체 제제
AP607A (en) Inhibiting photodecomposition of 3-substituted-2-oxindoles.
CA1069441A (fr) Produit pharmaceutique contenant de la 2,1,3-benzothiazole
CA2003478A1 (fr) Combinaison d'un inhibiteur de hmg coa reductase et d'un autre type d'agent reducteur du cholesterol serique et methode de reduction du cholesterol serique par l'emploi de ladite combinaison
CA2216931A1 (fr) Inhibition de la photodecomposition des 2-oxindoles-3-substitues
US4188393A (en) Treating spastic conditions or relaxing muscles
TW577741B (en) Novel pharmaceutical combination for treating pain comprising paracetamol and buspirone
EP0444546B1 (fr) Dérivés de l'hydantoine pour l'utilisation comme agents hypoglycémiques et/ou hypolipidémiques
US4333945A (en) Thiazoline and imidazoline derivatives useful as minor tranquilizers
NL193821C (nl) Farmaceutisch preparaat.
AU620658B2 (en) Memory-enhancing compositions containing dioxopiperidine derivatives
MXPA97008155A (en) Inhibition of the photo-composition of 2-oxindoles 3-substitute